Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2003
02/20/2003WO2002064758A9 An optical method for testing sensitivity of cells
02/20/2003WO2002064556A3 Complex carbohydrate arrays and methods for the manufacture and uses thereof
02/20/2003WO2002064026A3 Treating pulmonary disorders with gaseous agent causing repletion of gsno
02/20/2003WO2002062821A3 Peptide or protein microassay method and apparatus
02/20/2003WO2002061423A3 Identification of individual cells during kinetic assays
02/20/2003WO2002061057A3 Regulation of human wee1-like serine/threonine protein kinase
02/20/2003WO2002059623A3 Methods for determining platelet activity with antiplatelet compositions
02/20/2003WO2002057307A3 Genes
02/20/2003WO2002052012A8 Sugar beet genes involved in stress tolerance
02/20/2003WO2002044733A3 Methods and compositions for sorting and/or determining microorganisms
02/20/2003WO2002044400A3 Compositions and methods for extracting a nucleic acid
02/20/2003WO2002044335A3 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions
02/20/2003WO2002043829A3 Method and device for continuously treating waste water of industrial origin by water vapour stripping
02/20/2003WO2002034392B1 Vessel centering system and method
02/20/2003WO2002033376A3 Polypeptides inhibiting hepatitis c virus internal ribosome entry site (ires), and method for screening said polypeptides
02/20/2003WO2002031477A9 Fiber optic apparatus and use thereof in combinatorial material science
02/20/2003WO2002029088A9 Highly expressible genes
02/20/2003WO2002029087A9 Use of lymphangiogenic agents to treat lymphatic disorders
02/20/2003WO2002027322A9 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein
02/20/2003WO2002026950A3 Transferases
02/20/2003WO2002026193A9 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
02/20/2003WO2002021123A9 Improvements in instruments for measuring the total organic carbon content of water
02/20/2003WO2002014857B1 Direct selection of protein complexes relevant to the physiological or diagnostic context of a biological specimen
02/20/2003WO2001073109A3 Continuous process for manufacture of disposable electro-chemical sensor
02/20/2003WO2001064949A9 Diagnostics and therapeutics for glaucoma
02/20/2003US20030037353 Animal model for flaviviridae infection
02/20/2003US20030037350 Nucleotide sequences coding polypeptides for use in the treatment and diagnosis of cancer and nervous system disorders
02/20/2003US20030037345 Compositions and methods for wound healing
02/20/2003US20030036857 Methods and systems of biomolecular sequence matching
02/20/2003US20030036853 Automated assay for identification of individual cells during kinetic assays
02/20/2003US20030036742 Liquid specimen collection system
02/20/2003US20030036711 Method for determining the viscosity of an adulterated blood sample over plural shear rates
02/20/2003US20030036646 Uncoupling protein polynucleotides, polypeptides, and antibodies
02/20/2003US20030036645 Breast cancer resistance protein (BCRP) and the DNA which encode it
02/20/2003US20030036643 Methods and compositions for the construction and use of fusion libraries
02/20/2003US20030036634 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036631 Protein for use in the treatment of asthma, leukemia, or other allergic or inflammatory defects
02/20/2003US20030036630 Nucleotide sequences for use in human therapeutics and diagnostics
02/20/2003US20030036533 Used in infections by viruses, bacteria, fungi, and parasites
02/20/2003US20030036526 Activating a signaling cascade comprising, introducing leptin and/or a cytokine to a receptor complex comprising gp 130, to genes in neuro- endocrine cells or cells of neuro-endocrine origin.
02/20/2003US20030036506 Mutated class I major histocompatibility proteins and complexes
02/20/2003US20030036503 Method for separating a chemical or biological compound in a mixture of similar compounds by diffusion in a medium such as a gel
02/20/2003US20030036208 Drug screening and diagnosis based on paracrine tubular renin-angiotensin system
02/20/2003US20030036207 Storage of peptide data in computers; obtain sample, record spectral analysis, compare to controls, order data in library
02/20/2003US20030036205 Method for making microsensor arrays for detecting analytes
02/20/2003US20030036203 Diagnosing cardiovascular disorders in humans; obtain sample, incubate with signal generating particle, generate values for signa, graph results, evaluate graphic data for cardiovascular disorder
02/20/2003US20030036202 Methods and devices for use in analyte concentration determination assays
02/20/2003US20030036200 Monitoring glucose concentration of blood; obtain sensor package, insert blood, expose to test apparatus, analyze sample and determine glucose concentration
02/20/2003US20030036199 Kit for use in the diagnosis and treatment of cancer
02/20/2003US20030036194 Genetically engineered cell for use in regenerative medicine
02/20/2003US20030036188 Apparatus for patterning cells in a microarray
02/20/2003US20030036185 Novel amino acid sequences for human kidney cadherin-like polypeptides
02/20/2003US20030036184 Polypeptides exhibiting PDE7 activity and their use for selecting compounds which inhibit PDE 7 enzyme activity
02/20/2003US20030036182 Blocked immunoglobulin comprising antibody portion having heavy or light chain variable region; and Protein A portions; tethered to solid support; antibody sandwich, enzyme-linked immunosorbent, antibody dipstick, antibody microarray, radioimmuno-, or rolling circle amplification assay
02/20/2003US20030036180 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders
02/20/2003US20030036179 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036169 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's diseases
02/20/2003US20030036166 ErbB4 receptor-specific neuregulin related ligands and uses therefor
02/20/2003US20030036165 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders
02/20/2003US20030036162 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036161 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036146 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
02/20/2003US20030036140 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036137 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders
02/20/2003US20030036121 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036119 Nucleotide sequences coding polypeptides for use in the treatment, diagnosis and prevention of cell proliferative disorders
02/20/2003US20030036118 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036112 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders
02/20/2003US20030036110 Isolation of viral envelope proteins; obtain cells transform with vector containing viral protein, propagate cell, lyse cells, recover envelope proteins
02/20/2003US20030036108 Detection of cell fusion; obtain cells, measure fluorescence resonance energy transfer, compare to control and evaluate fusion
02/20/2003US20030036107 Modulators of leukocyte activation, compositions and methods of use
02/20/2003US20030036106 Detecting phosphorylated amino acid in sample; obtain sample, measure fluorescent polarization, of soluton, incubate with second fluorescent compound, measure and compare fluorescence
02/20/2003US20030036104 Detection of mycobacteria
02/20/2003US20030036103 Methods and compositions for diagnosis and treatment of vascular conditions
02/20/2003US20030036100 Simultaneous determination of phenotype and genotype
02/20/2003US20030036099 Isolation of membrane bound ligand-specific complexes
02/20/2003US20030036098 Axial pattern analysis utilizing organisms having defined marker patterns
02/20/2003US20030036096 Chemical-library composition and method
02/20/2003US20030036095 Detection of preferential pariticles in sample; obtain solid support, incubate with sample, detect signal from bound complexes
02/20/2003US20030036094 Nucleotide sequences coding polypeptide for use in the treatment of kidney, skin and cancer disorders
02/20/2003US20030036090 Relaxing solid support for use in biopolymer analysis; obtain relaxable solid support, expose to heat, monitor relaxation of solid support
02/20/2003US20030036082 Screening methods
02/20/2003US20030036078 P5CRs as modifiers of the p53 pathway and methods of use
02/20/2003US20030036076 CADs as modifiers of the p53 pathway and methods of use
02/20/2003US20030036075 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders
02/20/2003US20030036071 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression
02/20/2003US20030036062 Treatment of substrates for immobilizing biomolecules
02/20/2003US20030036061 Nucloetide sequences coding polypeptide for use in the treatment and diagnosis of infections,cancer, skin, cardiovascular and gastrointestinal disorders
02/20/2003US20030036060 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036054 Biosensor and related method
02/20/2003US20030036051 Methods of screening for antagonists and agonists of polypeptides having kinase functions
02/20/2003US20030036049 Testing drug sensitivity of cells; obtain cells, culture, incubate with test drug, expose to probe, detect signal, determine drug sensitivity
02/20/2003US20030035869 Identification method for purely natural products
02/20/2003US20030035815 Recombitope peptides
02/20/2003US20030035802 Angiogenosis inhibitors; antitumor, anticancer agents
02/20/2003US20030035800 Glycosylated humanized B-cell specific antibodies
02/20/2003US20030035773 Diagnosis of rheumatic diseases
02/20/2003US20030035758 Devices for incorporating filters for filtering fluid samples
02/20/2003US20030035757 Staining liquid sample; applying stresses; calibration
02/20/2003US20030035352 Optical disc system and related detecting methods for analysis of microscopic structures
1 ... 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 ... 3937